Early transfusion of a large cohort of COVID-19 patients with high titer anti-SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality
Eric Salazar, Paul A. Christensen, Edward A. Graviss, Duc T. Nguyen, Brian Castillo, Jian Chen, Bevin Valdez Lopez, Todd N. Eagar, Xin Yi, Picheng Zhao, John Rogers, Ahmed Shehabeldin, David Joseph, Faisal Masud, Christopher Leveque, Randall J. Olsen, David W. Bernard, Jimmy Gollihar, James M. Musser
doi: https://doi.org/10.1101/2020.10.02.20206029
Eric Salazar
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
bDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York
Paul A. Christensen
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Edward A. Graviss
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
cCenter for Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute, Houston, Texas
Duc T. Nguyen
cCenter for Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute, Houston, Texas
Brian Castillo
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Jian Chen
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Bevin Valdez Lopez
dAcademic Office of Clinical Trials, Houston Methodist Research Institute, Houston, Texas
Todd N. Eagar
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
bDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York
Xin Yi
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
bDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York
Picheng Zhao
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
John Rogers
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Ahmed Shehabeldin
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
David Joseph
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Faisal Masud
eDepartment of Anesthesiology and Critical Care, Houston Methodist Hospital, Houston, Texas
Christopher Leveque
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
Randall J. Olsen
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
bDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York
cCenter for Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute, Houston, Texas
David W. Bernard
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
bDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York
Jimmy Gollihar
fCCDC Army Research Laboratory-South, University of Texas at Austin, Austin, Texas
James M. Musser
aDepartment of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas
bDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York
cCenter for Molecular and Translational Human Infectious Diseases, Houston Methodist Research Institute, Houston, Texas
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted October 05, 2020.
Early transfusion of a large cohort of COVID-19 patients with high titer anti-SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality
Eric Salazar, Paul A. Christensen, Edward A. Graviss, Duc T. Nguyen, Brian Castillo, Jian Chen, Bevin Valdez Lopez, Todd N. Eagar, Xin Yi, Picheng Zhao, John Rogers, Ahmed Shehabeldin, David Joseph, Faisal Masud, Christopher Leveque, Randall J. Olsen, David W. Bernard, Jimmy Gollihar, James M. Musser
medRxiv 2020.10.02.20206029; doi: https://doi.org/10.1101/2020.10.02.20206029
Early transfusion of a large cohort of COVID-19 patients with high titer anti-SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality
Eric Salazar, Paul A. Christensen, Edward A. Graviss, Duc T. Nguyen, Brian Castillo, Jian Chen, Bevin Valdez Lopez, Todd N. Eagar, Xin Yi, Picheng Zhao, John Rogers, Ahmed Shehabeldin, David Joseph, Faisal Masud, Christopher Leveque, Randall J. Olsen, David W. Bernard, Jimmy Gollihar, James M. Musser
medRxiv 2020.10.02.20206029; doi: https://doi.org/10.1101/2020.10.02.20206029
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (670)
- Anesthesia (181)
- Cardiovascular Medicine (2652)
- Dermatology (224)
- Emergency Medicine (400)
- Epidemiology (12242)
- Forensic Medicine (10)
- Gastroenterology (762)
- Genetic and Genomic Medicine (4113)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2664)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (852)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3896)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (586)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6537)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (410)
- Sports Medicine (343)
- Surgery (451)
- Toxicology (53)
- Transplantation (185)
- Urology (166)